Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2010, Vol. 30 Issue (11): 65-69    DOI:
    
Expression and Application Research of the C-terminal Gene Fragment of P1 Protein of Mycoplasma pneumoniae in E.coli
HUANG Jin-song1, HUANG Jie-qin2, TANG Qi-hui2, CHEN Yu-bao2
1. Beijing Academy of Sciences and Technology, Science and Technology Department,Beijing 100094,China;
2. Beijing Biokit Incorporated, Beijing 100094,China
Download: HTML   PDF(652KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective:To clone, express and characterize the C-terminal gene fragment of P1 protein. Methods:On the basis of successful clone and sequence analysis of the C-terminal gene fragment of P1,the gene fragment were ligated into pET32a(+).An expression vector pET32a(+)/ P1(3 520~4 563bp)were constructed and expressed in E.coli rosetta induced by IPTG. recombinant protein was purified through GSTrap 4B affinity chromatography column. ELISA and Western blotting were used to determine the antigenic of the recombinant protein. Immune mouse with recombination protein, monoclonal antibody was prepared. Results:The recombinant gene can be overexpressed in E.coli. SDS analysis revealed that the expressed protein was identical to C-terminal gene fragment of P1 protein in molecular weight with a purity of 95%. ELISA and Western blotting analysis showed that the recombinant protein can displayed high antigenic activity toward Mycoplasma pneumoniae convalescent antiserum. Two monoclonal antibody cell line were obtained. Conclusion:The C-terminal gene fragment of P1 protein of MP has been successful cloned and expressed, monoclonal antibody was prepared which could be useful for developing diagnose reagents or vaccine of MP.



Key wordsMycoplasma pneumoniae      C-terminal gene fragment of P1 protein      Clone and express      Monoclonal antibody     
Published: 19 November 2010
ZTFLH:  Q78  
Cite this article:

HUANG Jin-song, HUANG Jie-qin, TANG Qi-hui, CHEN Yu-bao. Expression and Application Research of the C-terminal Gene Fragment of P1 Protein of Mycoplasma pneumoniae in E.coli. China Biotechnology, 2010, 30(11): 65-69.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2010/V30/I11/65

[1] Chanock R M,Hayflick L,Barile M F,Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.Natl Acad Sci USA,1962,48:41-49.
[2] Grayston J T,Alexander E R,Kenny G E,et al.Mycoplasma pneumoniae infections:clinical and epidemiologic studies.J Am Med Assoc,1962,191:369-374.
[3] Hu P C,Collier A M,Baseman J B.Surface parasitism by Mycoplasma pneumoniae of respiratory epithelium.J Exp Med,1977,145:1328-1343.
[4] Feldner J,Gobel U,Bredt W.Mycoplasma pneumoniae adhesin localized to tip structure by monoclonal antibody.Nature,1982,298:765-767.
[5] Razin S.Adherence of pathogenic mycoplasmas to host cells.Biosci Rep,1999,19:367-372.
[6] Layh-Schmitt G,Podtelejnikov A,Mann M.Proteins comlplexed to the P1 adhesin of Mycoplasma pneumoniae.Microbiology,2000,146(3):741.
[7] Dorigo-Zetsma J W,Wilbrink B,Dankert J,et al.Mycoplasma pneumoniae P1 type 1 and type 2 specific sequences within the P1 cytadhesin gene of individual strains. Infect Immun,2001,69(9):5612-5618.
[8] Kenri T,Taniguchi R,Sasaki Y,et al.Identification of a new variable sequence in the P1 cytadhesin of antigenic variation by DNA recombination between repetitive sequences..Infect Immun,1999,67(9):4557-4562.
[9] Inamine J M,Denny T P,Loechel S,et al.Nucleotide sequence of the P1 attachment-protein gene of Mycoplasma pneumoniae.Gene,1988,64(2):217.
[10] Rocha E P,Blanchard A.Genomic repeats,genome plasticity and the dynamics of Mycoplasma evolution.Nucletic Acids Research,2002,30(9)2031-2042.
[11] Gerstenecker B,Jacobs E.Topological mapping of the P1-adhesin of Mycoplasma pneumoniae with adherence-inhibiting monoclonal antibodyies.J Gen Microbiol,1990,136(3):471.
[12] Himmelreich R,Hilbert H,Plagens H,et al.Complete sequence analysis of the genome of the bacterium Mycoplasma Pneumoniae.Nucleic Acids Research,1996,24(22):4420-4449.
[13] Bitnun A,Ford-Jones E L, Petric M, et al.Acute childhood encephalitis and Mycoplasma pneumoniae.Clin Infect Dis,2001,32:1674-1684.
[14] Dandekar T,Huynen M,Regula J T,et al.Re-annotating the Mycoplasma pneumoniae genome sequence:adding value,function and reading frames.Nucleic Acids Res,2000,28(17):3278-3288.
[15] Gerstenecker B,Jacobs E.Topological mapping of the P1-adhesin of Mycoplasma pneumoniae with adherence-inhibiting monoclonal antibodies.J Gen Microbiol,1990,136:471-476.
[16] Su C J,Tryon V V,Baseman J B.Cloning and sequence analysis of cytadhesin P1 gene from Mycoplasma pneumoniae.Infect Immun,1987,55:3023-3029.
[17] Svenstrup H F,Nielsen P K,Drasbek M,et al.Adhesion and inhibition assay of Mycoplasma genitalium and M. pneumoniae by immunofluorescence microscopy.J Med Microbiol,2002,51:361-373.
[18] Dallo S F,Su C J,Horton J R,et al.Identification of P1gene dominant containing epitopel(s) mediating Mycoplasma pneumoniae cytadherence.J Exp Med,1998,167(2):718-723.
[19] Krause D C.Mycoplasma pneumoniae cytadherence: unravelling the tie that binds.Mol Microbiol,1996,20:247-253.
[20] Inamine J M,Ho K C,Loechel S,et al.Evidence that UGA is read as a tryptophan codon rather than as a stop codon by Mycoplasma genitalium,and Mycoplasma gallisepticum.J Bacteriol,1990,172:504-506.
[21] Yamao F A,Muto Y,Kawauchi M,et al.UGA is read as tryptophan in Mycoplasma capricolum.Proc J Natl Acad Sci USA,1990,82:2306-2309.

[1] ZHAO Yan-shu,ZHANG Jin-hua,SONG Hao. Advances in Production of Monoclonal Antibody and Antibody Fragments in Engineered Prokaryotes and Yeast[J]. China Biotechnology, 2020, 40(8): 74-83.
[2] WANG Meng,SONG Hui-ru,CHENG Yu-jie,WANG Yi,YANG Bo,HU Zheng. Accurate Detection of Streptococcus pneumoniae by Using Ribosomal Protein L7 / L12 as Molecular Marker[J]. China Biotechnology, 2020, 40(4): 34-41.
[3] JIANG Yi-fan,JIA Yu,Wang Long,WANG Zhi-ming. The Glycosylation Design and Control of Monoclonal Antibody by Cell Culture[J]. China Biotechnology, 2019, 39(8): 95-103.
[4] LIU Guo-fang,LIU Xiao-zhi,GAO Jian,WANG Zhi-ming. Effects of Host Cell Residual Proteins on the Quality and Their Quality Control of Monoclonal Antibody[J]. China Biotechnology, 2019, 39(10): 105-110.
[5] Jian-wei REN,Jun LI,Shang-ze LI. Human CT55 Protein Prokaryotic Expression and Its Production of Monoclonal Antibody[J]. China Biotechnology, 2018, 38(11): 1-8.
[6] Kai-yun MAO,Yue-lei FAN,Heng-zhe WANG,Da-ming CHEN. Market Competition Pattern of Global PD-1/PD-L1 Monoclonal Antibody[J]. China Biotechnology, 2018, 38(11): 103-115.
[7] Jing-jing SUN,Wei-wei ZHOU,Lei-ming ZHOU,Qiao-hui ZHAO,Gui-lin LI. Advance in Large-Scale Culture of Hybridoma Cells in Vitro[J]. China Biotechnology, 2018, 38(10): 82-89.
[8] WANG Yun-long, ZHAO Er-xia, LI Yu-lin. Expression, Purification and Identification of Thymidine Kinase 1 Recombinant Protein[J]. China Biotechnology, 2017, 37(9): 15-22.
[9] WU Meng-ling, ZHOU Jia-wang, DU Jun. Development and Application of A Double Monoclonal Antibody Sandwich ELISA for the Assay of Nodal[J]. China Biotechnology, 2017, 37(3): 51-57.
[10] LI Min, WU Ri-wei. The Market Overview of Monoclonal Antibodies in Both Domestic and Abroad[J]. China Biotechnology, 2017, 37(3): 106-114.
[11] REN Hua-jing, LIU Xiao-zhi, WANG Zhi-ming, GAO Jian. Progression of Central Nervous System Disease Therapeutic Antibody Drug Application[J]. China Biotechnology, 2016, 36(9): 54-58.
[12] ZHANG Yin-chuan, LIU Meng-meng, ZHANG Ya-ting, GUI Fang, ZHANG Ai-hua, BI Lan, PAN Yong-bin. Construction and Screening of Recombinant Cell Line Expressing Fully-human mAbs against Human IgE[J]. China Biotechnology, 2015, 35(3): 66-74.
[13] WANG Lan, XIA Mao, GAO Kai. The Development and Quality Control of Antibody-Drug Conjugates[J]. China Biotechnology, 2014, 34(4): 85-94.
[14] GAO Kai, XU Zhi-kai, REN Yue-ming, WAN Lan, WANG Jun-zhi, GUO Zhong-ping. Points to Consider for the General Monograph of Monoclonal Antibody Based Biotherapeutics in Chinese Pharamacopeia[J]. China Biotechnology, 2014, 34(1): 127-134.
[15] LI Ming-zhu, HAN Wei-dong, Xing Guang-hui, TENG Zhen-lin, XUE Guo-mei, HOU Chen-rui, RUAN Hong-qiang, CHEN Wei. Research of N Terminal Sequencing Methods for Monoclonal Antibody Pharmaceuticals Blocked by Pyroglutamic Acid[J]. China Biotechnology, 2013, 33(8): 75-83.